title: Partial characterization of endogenous modulators of muscarinic acetylcholine receptors in human frontal cortex.
abstract: A soluble fraction from human frontal cortex with molecular weight less than 10 kD was tested for the presence of endogenous substances capable of modulating the [3H]-QNB binding to crude P1 + P2 fractions from the same region. The soluble fraction was able to decrease [3H]-QNB binding in a dose-response manner with an IC50 of about 30 micrograms/ml. The effect appeared to be noncompetitive in nature, since Bmax but not Kd was significantly affected; however, in some specimens a biphasic profile, with an initial inhibition of 88-90% of [3H]-QNB binding and 50-60% ulterior binding recuperation was also found. The modulator appeared to have a molecular weight less than 10,000 Daltons and was heat and trypsin resistant. These results point out the existence of an endogenous factor, which could be heterogeneous in regard to its molecular nature or to its action sites.
authors.affiliation: Unidad de Bioquímica, Universidad Centroccidental Lisandro Alvarado, Barquisimeto, Venezuela.
authors.forename: N E
authors.initials: NE
authors.lastname: Loureiro-Dos Santos
authors.forename: C S
authors.initials: CS
authors.lastname: Rodríguez-Valenzuela
authors.forename: R A
authors.initials: RA
authors.lastname: Bonfante-Cabarcas
authors.forename: C
authors.initials: C
authors.lastname: Pascuzzo-Lima
authors.forename: J A
authors.initials: JA
authors.lastname: Moreno-Yanes
mesh_terms: D000293:Adolescent; D000328:Adult; D001667:Binding, Competitive; D002799:Cholinergic Fibers / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005625:Frontal Lobe / Q000737:chemistry*; D006801:Humans; D008297:Male; D008861:Microsomes / Q000737:chemistry; D008970:Molecular Weight; D018721:Muscarinic Agonists / Q000302:isolation & purification* / Q000378:metabolism; D018727:Muscarinic Antagonists / Q000302:isolation & purification* / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000187:drug effects* / Q000302:isolation & purification; D018377:Neurotransmitter Agents / Q000302:isolation & purification* / Q000378:metabolism; D011489:Protein Denaturation; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000187:drug effects* / Q000302:isolation & purification; D012995:Solubility
chemical_list: D018721:Muscarinic Agonists; D018727:Muscarinic Antagonists; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D011976:Receptors, Muscarinic; D011813:Quinuclidinyl Benzilate